688179 阿拉丁
已收盘 12-12 15:00:00
资讯
新帖
简况
阿拉丁（688179）披露2025年前三季度利润分配方案，12月10日股价下跌1.21%
证券之星 · 12-10 22:16
阿拉丁（688179）披露2025年前三季度利润分配方案，12月10日股价下跌1.21%
阿拉丁：喀斯玛控股2023年利润较高主要源于非经常性收益
证券日报网 · 12-10 21:39
阿拉丁：喀斯玛控股2023年利润较高主要源于非经常性收益
阿拉丁：12月8日接受机构调研，西部证券、中国人保资产等多家机构参与
证券之星 · 12-10 19:02
阿拉丁：12月8日接受机构调研，西部证券、中国人保资产等多家机构参与
【机构调研记录】国投瑞银基金调研阿拉丁
证券之星 · 12-08
【机构调研记录】国投瑞银基金调研阿拉丁
【私募调研记录】万丰友方调研阿拉丁
证券之星 · 12-08
【私募调研记录】万丰友方调研阿拉丁
阿拉丁：12月4日接受机构调研，包括知名机构银叶投资的多家机构参与
证券之星 · 12-05
阿拉丁：12月4日接受机构调研，包括知名机构银叶投资的多家机构参与
阿拉丁(688179.SH)拟收购佑科35%股权 丰富产品线
智通财经 · 11-26
阿拉丁(688179.SH)拟收购佑科35%股权 丰富产品线
阿拉丁（688179）披露召开2025年第三季度业绩说明会，11月24日股价上涨1.52%
证券之星 · 11-24
阿拉丁（688179）披露召开2025年第三季度业绩说明会，11月24日股价上涨1.52%
每周股票复盘：阿拉丁（688179）国产替代持续推进，SCI引用超25万篇
证券之星 · 11-23
每周股票复盘：阿拉丁（688179）国产替代持续推进，SCI引用超25万篇
阿拉丁（688179）披露股东完成证券非交易过户，11月19日股价下跌2.84%
证券之星 · 11-19
阿拉丁（688179）披露股东完成证券非交易过户，11月19日股价下跌2.84%
阿拉丁：11月17日接受机构调研，唐祺资产、渤海资产等多家机构参与
证券之星 · 11-19
阿拉丁：11月17日接受机构调研，唐祺资产、渤海资产等多家机构参与
【机构调研记录】诺安基金调研荣昌生物、阿拉丁
证券之星 · 11-13
【机构调研记录】诺安基金调研荣昌生物、阿拉丁
【机构调研记录】兴证全球基金调研阿拉丁
证券之星 · 11-13
【机构调研记录】兴证全球基金调研阿拉丁
股市必读：阿拉丁（688179）11月12日披露最新机构调研信息
证券之星 · 11-13
股市必读：阿拉丁（688179）11月12日披露最新机构调研信息
每周股票复盘：阿拉丁（688179）Q3净利增15.8%并购致资产增45.13%
证券之星 · 11-02
每周股票复盘：阿拉丁（688179）Q3净利增15.8%并购致资产增45.13%
图解阿拉丁三季报：第三季度单季净利润同比增长15.80%
证券之星 · 10-30
图解阿拉丁三季报：第三季度单季净利润同比增长15.80%
阿拉丁（688179）披露2025年第三季度报告，10月29日股价上涨0.57%
证券之星 · 10-29
阿拉丁（688179）披露2025年第三季度报告，10月29日股价上涨0.57%
每周股票复盘：阿拉丁（688179）加码并购布局国产替代
证券之星 · 10-26
每周股票复盘：阿拉丁（688179）加码并购布局国产替代
阿拉丁（688179）披露2024年度持续督导现场检查报告，10月20日股价上涨0.5%
证券之星 · 10-20
阿拉丁（688179）披露2024年度持续督导现场检查报告，10月20日股价上涨0.5%
每周股票复盘：阿拉丁（688179）股东减持240万股占比0.7216%
证券之星 · 10-19
每周股票复盘：阿拉丁（688179）股东减持240万股占比0.7216%
公司概况
公司名称：
上海阿拉丁生化科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2020-10-26
主营业务：
上海阿拉丁生化科技股份有限公司的主营业务是科研试剂的研发、生产及销售。公司的主要产品是科研试剂。
发行价格：
19.43
{"stockData":{"symbol":"688179","market":"SH","secType":"STK","nameCN":"阿拉丁","latestPrice":12.93,"timestamp":1765522800000,"preClose":12.98,"halted":0,"volume":4906609,"delay":0,"changeRate":-0.0039,"floatShares":333000000,"shares":333000000,"eps":0.2525,"marketStatus":"已收盘","change":-0.05,"latestTime":"12-12 15:00:00","open":12.9,"high":13.09,"low":12.82,"amount":63535800,"amplitude":0.0208,"askPrice":12.95,"askSize":10,"bidPrice":12.93,"bidSize":758,"shortable":0,"etf":0,"ttmEps":0.2525,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":12.98,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":14.28,"lowLimit":11.68,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":332606902,"isCdr":false,"pbRate":4.24,"roa":"--","peRate":51.207921,"roe":"5.03%","epsLYR":0.36,"committee":0.291838,"marketValue":4301000000,"turnoverRate":0.0148,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-15。","afterMarket":{"amount":0,"volume":0,"close":12.93,"buyVolume":0,"sellVolume":0,"time":1765524837768,"indexStatus":"已收盘 12-12 15:30:00","preClose":12.98},"floatMarketCap":4301000000},"requestUrl":"/m/hq/s/688179/wiki","defaultTab":"wiki","newsList":[{"id":"2590538205","title":"阿拉丁（688179）披露2025年前三季度利润分配方案，12月10日股价下跌1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590538205","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590538205?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:16","pubTimestamp":1765376169,"startTime":"0","endTime":"0","summary":"根据公司近日发布的公告，上海阿拉丁生化科技股份有限公司拟实施2025年前三季度利润分配方案，计划每10股派发现金红利0.70元（含税），以实施权益分派股权登记日登记的总股本扣减公司回购专用证券账户中的股份为基数。截至2025年9月30日，公司总股本为332,606,902股，扣除回购股份后剩余331,304,862股，预计派发现金红利23,191,340.34元（含税）。若股权登记日前公司总股本发生变动，将维持每股分配比例不变，相应调整分配总额。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000041610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688179","BK0216"],"gpt_icon":0},{"id":"2590580568","title":"阿拉丁：喀斯玛控股2023年利润较高主要源于非经常性收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2590580568","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590580568?lang=zh_cn&edition=full","pubTime":"2025-12-10 21:39","pubTimestamp":1765373940,"startTime":"0","endTime":"0","summary":"证券日报网12月10日讯阿拉丁在12月8日回答调研者提问时表示，喀斯玛控股2023年利润较高主要源于非经常性收益，即下属参股企业资产处置产生的投资收益，而非主营业务贡献，因此利润有所波动 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20251210/c673115670.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251210/c673115670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688179","BK0216"],"gpt_icon":0},{"id":"2590269586","title":"阿拉丁：12月8日接受机构调研，西部证券、中国人保资产等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2590269586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590269586?lang=zh_cn&edition=full","pubTime":"2025-12-10 19:02","pubTimestamp":1765364534,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年12月10日阿拉丁发布公告称公司于2025年12月8日接受机构调研，西部证券、中国人保资产、富安达基金参与。答：喀斯玛控股2023年利润较高主要源于非经常性收益，即下属参股企业资产处置产生的投资收益，而非主营业务贡献，因此利润有所波动。阿拉丁主营业务：科研试剂的研发、生产及销售,同时配套少量实验耗材。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000031119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1979443071.USD","BK0188","601319","BK0216","LU1934453819.USD","002673","BK0207","BK0276","BK0028","BK0183","688179"],"gpt_icon":0},{"id":"2589801081","title":"【机构调研记录】国投瑞银基金调研阿拉丁","url":"https://stock-news.laohu8.com/highlight/detail?id=2589801081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589801081?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:01","pubTimestamp":1765152078,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月5日披露的机构调研信息，国投瑞银基金近期对1家上市公司进行了调研，相关名单如下：1）阿拉丁 调研纪要：公司通过电商模式并与海外经销商合作进行销售，海外网站放开后陆续产生订单，海外仓储完善将加快销售速度。国投瑞银基金成立于2002年，截至目前，资产管理规模2397.89亿元，排名34/211；资产管理规模1382.11亿元，排名36/211；管理公募基金数217只，排名31/211；旗下公募基金经理32人，排名41/211。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800000267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688179"],"gpt_icon":0},{"id":"2589735801","title":"【私募调研记录】万丰友方调研阿拉丁","url":"https://stock-news.laohu8.com/highlight/detail?id=2589735801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589735801?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:01","pubTimestamp":1765152062,"startTime":"0","endTime":"0","summary":"根据市场公开信息及12月5日披露的机构调研信息，知名私募万丰友方近期对1家上市公司进行了调研，相关名单如下：1）阿拉丁 调研纪要：公司通过电商模式并与海外经销商合作进行销售，海外网站放开后陆续产生订单，海外仓储完善将加快销售速度。数年前躬身入局，数年来深耕不辍，为万丰友方系统化、智能化投资打下坚实的基础。对过去唯有感恩，对未来唯有前行，万丰友方始终在路上，不忘初心，敢于创新，愿得始终。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025120800000234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688179","BK0216"],"gpt_icon":0},{"id":"2589899529","title":"阿拉丁：12月4日接受机构调研，包括知名机构银叶投资的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2589899529","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589899529?lang=zh_cn&edition=full","pubTime":"2025-12-05 19:02","pubTimestamp":1764932544,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年12月5日阿拉丁发布公告称公司于2025年12月4日接受机构调研，中信证券、兆顺基金、红杉资本、德盛安联、银叶投资、彬元资本、君和资本、首创证券、霁峰资本、国泰海通证券、招商基金、合众易晟、国信证券、国投瑞银基金、万丰友方、浙商资管、华泰证券、翊安投资参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500030386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688179"],"gpt_icon":0},{"id":"2586232049","title":"阿拉丁(688179.SH)拟收购佑科35%股权 丰富产品线","url":"https://stock-news.laohu8.com/highlight/detail?id=2586232049","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586232049?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:58","pubTimestamp":1764147493,"startTime":"0","endTime":"0","summary":"智通财经APP讯，阿拉丁(688179.SH)公告，公司与上海佑科仪器仪表有限公司(“佑科”)签订《股权转让意向协议》，公司拟以支付现金的方式购买佑科35%的股权，交易价格为6125万元。投资完成后，公司将持有佑科35%的股权，佑科将成为公司的参股子公司。对佑科的投资，有利于丰富公司在实验室通用分析仪器领域的产品线，能够更好地便利客户一站式采购及增加客户粘性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688179"],"gpt_icon":0},{"id":"2585549885","title":"阿拉丁（688179）披露召开2025年第三季度业绩说明会，11月24日股价上涨1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585549885","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585549885?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:22","pubTimestamp":1763994177,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，阿拉丁报收于12.69元，较前一交易日上涨1.52%，最新总市值为42.21亿元。该股当日开盘12.63元，最高12.79元，最低12.54元，成交额达4983.71万元，换手率为1.18%。近日，阿拉丁发布关于召开2025年第三季度业绩说明会的公告。公告称，上海阿拉丁生化科技股份有限公司将于2025年12月02日09:00-10:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会，介绍公司2025年第三季度经营成果及财务状况。说明会结束后可通过上证路演中心查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400035768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688179"],"gpt_icon":0},{"id":"2585010301","title":"每周股票复盘：阿拉丁（688179）国产替代持续推进，SCI引用超25万篇","url":"https://stock-news.laohu8.com/highlight/detail?id=2585010301","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585010301?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:12","pubTimestamp":1763838735,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，阿拉丁报收于12.5元，较上周的13.7元下跌8.76%。本周，阿拉丁11月17日盘中最高价报13.75元。据知了窝大数据平台统计，目前，阿拉丁产品的SCI论文引用总数已超25万篇，阿拉丁的文献增长数量每年均呈现出惊人的增长势头，说明客户对阿拉丁品牌的认可度在提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688179","BK0216"],"gpt_icon":0},{"id":"2584843947","title":"阿拉丁（688179）披露股东完成证券非交易过户，11月19日股价下跌2.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584843947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584843947?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:22","pubTimestamp":1763562145,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，阿拉丁报收于12.99元，较前一交易日下跌2.84%，最新总市值为43.21亿元。该股当日开盘13.28元，最高13.48元，最低12.93元，成交额达8429.37万元，换手率为1.93%。公司近日发布公告称，股东上海晶真文化艺术发展中心因解散清算，将其持有的公司股份7,381,190股通过非交易过户方式登记至各合伙人名下，过户已于2025年11月18日完成。过户后，相关合伙人将遵守股份减持限制及高管持股管理规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900039977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688179","161027","BK0216"],"gpt_icon":0},{"id":"2584847943","title":"阿拉丁：11月17日接受机构调研，唐祺资产、渤海资产等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2584847943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584847943?lang=zh_cn&edition=full","pubTime":"2025-11-19 19:31","pubTimestamp":1763551907,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月19日阿拉丁发布公告称公司于2025年11月17日接受机构调研，唐祺资产、渤海资产、国元证券参与。据知了窝大数据平台统计，目前，阿拉丁产品的SCI论文引用总数已超25万篇，阿拉丁的文献增长数量每年均呈现出惊人的增长势头，说明客户对阿拉丁品牌的认可度在提升。阿拉丁主营业务：科研试剂的研发、生产及销售,同时配套少量实验耗材。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900034156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688179","BK0216"],"gpt_icon":0},{"id":"2583582679","title":"【机构调研记录】诺安基金调研荣昌生物、阿拉丁","url":"https://stock-news.laohu8.com/highlight/detail?id=2583582679","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583582679?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:05","pubTimestamp":1762992349,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月12日披露的机构调研信息，诺安基金近期对2家上市公司进行了调研，相关名单如下：1）荣昌生物 调研纪要：2025年第三季度营业收入6.2亿元，环比增长8.7%；前三季度收入17.2亿元，同比增长42.3%。第三季度亏损1.01亿元，前三季度累计亏损5.5亿元，同比减亏48.6%。2）阿拉丁 调研纪要：公司下游覆盖生命科学、半导体、新能源等多个行业，企业端需求恢复较快，叠加高校扩招带动试剂需求上升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300007167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","BK0239","BK1161","09995","LU1064130708.USD","688331","688179","BK0216","BK1574","BK1583","LU2148510915.USD","LU1064131003.USD","LU2488822045.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2583258263","title":"【机构调研记录】兴证全球基金调研阿拉丁","url":"https://stock-news.laohu8.com/highlight/detail?id=2583258263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583258263?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:05","pubTimestamp":1762992312,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月12日披露的机构调研信息，兴证全球基金近期对1家上市公司进行了调研，相关名单如下：1）阿拉丁 调研纪要：公司下游覆盖生命科学、半导体、新能源等多个行业，企业端需求恢复较快，叠加高校扩招带动试剂需求上升。旗下最近一年表现最佳的公募基金产品为兴证全球创新优势混合A，最新单位净值为1.7，近一年增长53.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300007117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688179","BK0216"],"gpt_icon":0},{"id":"2583185307","title":"股市必读：阿拉丁（688179）11月12日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2583185307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583185307?lang=zh_cn&edition=full","pubTime":"2025-11-13 04:23","pubTimestamp":1762978989,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，阿拉丁报收于13.28元，下跌0.08%，换手率1.39%，成交量4.62万手，成交额6094.47万元。公司公告汇总上海阿拉丁生化科技股份有限公司于2025年11月11日披露简式权益变动报告书。本次变动不涉及资金支付，且信息披露义务人无未来12个月内增减持计划。本次权益变动后，信息披露义务人合计持股比例由46.27%降至44.76%，不触及要约收购，亦未导致公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300004917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688179"],"gpt_icon":0},{"id":"2580472952","title":"每周股票复盘：阿拉丁（688179）Q3净利增15.8%并购致资产增45.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580472952","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580472952?lang=zh_cn&edition=full","pubTime":"2025-11-02 06:34","pubTimestamp":1762036453,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，阿拉丁报收于12.99元，较上周的12.18元上涨6.65%。本周，阿拉丁10月30日盘中最高价报13.15元。2025年第三季度单季度主营收入1.69亿元，同比上升21.26%；单季度归母净利润2929.68万元，同比上升15.8%；单季度扣非净利润2940.64万元，同比上升17.27%。公司公告汇总阿拉丁2025年第三季度报告显示，总资产为25.81亿元，较上年末增长45.13%，主因并购喀斯玛控股有限公司并新增银行贷款所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688179"],"gpt_icon":0},{"id":"2579488187","title":"图解阿拉丁三季报：第三季度单季净利润同比增长15.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579488187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579488187?lang=zh_cn&edition=full","pubTime":"2025-10-30 03:03","pubTimestamp":1761764601,"startTime":"0","endTime":"0","summary":"证券之星消息，阿拉丁2025年三季报显示，前三季度公司主营收入4.44亿元，同比上升17.59%；归母净利润5776.03万元，同比下降20.41%；扣非净利润5720.99万元，同比下降19.77%；其中2025年第三季度，公司单季度主营收入1.69亿元，同比上升21.26%；单季度归母净利润2929.68万元，同比上升15.8%；单季度扣非净利润2940.64万元，同比上升17.27%；负债率51.06%，投资收益313.19万元，财务费用1769.29万元，毛利率63.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000003031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688179"],"gpt_icon":0},{"id":"2579907907","title":"阿拉丁（688179）披露2025年第三季度报告，10月29日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579907907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579907907?lang=zh_cn&edition=full","pubTime":"2025-10-29 22:24","pubTimestamp":1761747854,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘，阿拉丁报收于12.35元，较前一交易日上涨0.57%，最新总市值为41.08亿元。近日，阿拉丁发布2025年第三季度报告，披露了公司前三季度主要财务数据。报告显示，年初至报告期末，公司实现营业收入444,035,088.59元，同比增长17.59%；归属于上市公司股东的净利润为57,760,251.02元，同比下降20.41%。股东信息方面，截至报告期末，公司普通股股东总数为11,577户。前十大股东中，徐久振持股27.72%，为公司第一大股东，招立萍持股14.85%，两人系夫妇关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900045243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688179","BK0216"],"gpt_icon":0},{"id":"2578850021","title":"每周股票复盘：阿拉丁（688179）加码并购布局国产替代","url":"https://stock-news.laohu8.com/highlight/detail?id=2578850021","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578850021?lang=zh_cn&edition=full","pubTime":"2025-10-26 04:45","pubTimestamp":1761425110,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，阿拉丁报收于12.18元，较上周的11.99元上涨1.58%。本周，阿拉丁10月22日盘中最高价报12.39元。国产替代一直在进行中。公司公告汇总西部证券股份有限公司于2025年10月14日对上海阿拉丁生化科技股份有限公司2024年度规范运作情况进行了现场检查。保荐人未发现需向中国证监会或交易所报告的重大事项。保荐人认为，阿拉丁2024年度运作符合相关监管要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688179"],"gpt_icon":0},{"id":"2576644863","title":"阿拉丁（688179）披露2024年度持续督导现场检查报告，10月20日股价上涨0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576644863","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576644863?lang=zh_cn&edition=full","pubTime":"2025-10-20 22:37","pubTimestamp":1760971031,"startTime":"0","endTime":"0","summary":"截至2025年10月20日收盘，阿拉丁报收于12.05元，较前一交易日上涨0.5%，最新总市值为40.08亿元。近日，西部证券股份有限公司发布了关于上海阿拉丁生化科技股份有限公司2024年度持续督导工作现场检查报告。公告显示，西部证券于2025年10月14日对阿拉丁2024年度规范运作情况进行了现场检查，检查内容涵盖公司治理及内部控制、信息披露、独立性、募集资金使用、关联交易、对外担保、重大对外投资及经营状况等方面。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000032538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688179"],"gpt_icon":0},{"id":"2576049127","title":"每周股票复盘：阿拉丁（688179）股东减持240万股占比0.7216%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576049127","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576049127?lang=zh_cn&edition=full","pubTime":"2025-10-19 03:48","pubTimestamp":1760816890,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，阿拉丁报收于11.99元，较上周的13.0元下跌7.77%。本周，阿拉丁10月13日盘中最高价报12.96元。减持前持股9,781,190股，占总股本2.94%。2025年6月21日披露减持计划，拟通过集中竞价方式减持不超过2,400,000股，占总股本0.7216%。减持期间为2025年8月11日至10月13日。本次减持后，晶真文化持股数量为7,381,190股，持股比例降至2.2192%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688179"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765616422547,"stockEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":-0.0264},{"period":"3month","weight":-0.0015},{"period":"6month","weight":0.0739},{"period":"1year","weight":-0.0559},{"period":"ytd","weight":0.1384}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海阿拉丁生化科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"11577人(较上一季度减少7.17%)","perCapita":"28729股","listingDate":"2020-10-26","address":"上海市奉贤区楚华支路809号","registeredCapital":"33260万元","survey":" 上海阿拉丁生化科技股份有限公司的主营业务是科研试剂的研发、生产及销售。公司的主要产品是科研试剂。","listedPrice":19.43},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阿拉丁(688179)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阿拉丁(688179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阿拉丁,688179,阿拉丁股票,阿拉丁股票老虎,阿拉丁股票老虎国际,阿拉丁行情,阿拉丁股票行情,阿拉丁股价,阿拉丁股市,阿拉丁股票价格,阿拉丁股票交易,阿拉丁股票购买,阿拉丁股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阿拉丁(688179)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阿拉丁(688179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}